XYL-4001
XYL-4001, formerly known as PSYLO-4001, is a non-hallucinogenic serotonin 5-HT 2A receptor agonist and psychoplastogen which is under development for the treatment of depressive disorders such as major depressive disorder.
≈ 1 min read
XYL-4001. encyclopegia.org, snapshot enwiki-001372054046. /a/xyl-4001
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
XYL-4001, formerly known as PSYLO-4001, is a non-hallucinogenic serotonin 5-HT 2A receptor agonist and psychoplastogen which is under development for the treatment of depressive disorders such as major depressive disorder. Its route of administration is unspecified. The drug is being developed by Xylo Bio (formerly known as Psylo).
As of January 2025, it is in the preclinical research stage of development. Its chemical structure does not yet appear to have been disclosed.
See also
List of investigational hallucinogens and entactogens List of investigational antidepressants Non-hallucinogenic 5-HT 2A receptor agonist
External links
Pipeline - Psylo
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372054046 under CC BY-SA 4.0; modifications have been made.